This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, Q Articles by Kenney, S Search for Related Content PubMed PubMed Citation Articles by Zhang, Q Articles by Kenney, S

Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.

Department of Medicine, University of North Carolina at Chapel Hill 27599.

ABSTRACT

The p53 tumor suppressor protein, which is commonly mutated in human cancers, has been shown to interact directly with virally encoded from papillomavirus, adenovirus, and simian virus 40. The disruption of p53 function may be required for efficient replication of certain viruses and may also play a role in the development of virally induced malignancies. Infection with Epstein-Barr virus (EBV) has been associated with the development of B-cell lymphomas and nasopharyngeal carcinoma. Here we show that the EBV immediate-early protein, BZLF1 (Z), which is responsible for initiating the switch from latent to lytic infection, can interact directly in vitro and in vivo with the tumor suppressor protein, p53. This interaction requires the coiled-coil dimerization domain of the Z protein and the carboxy-terminal portion of p53. Overexpression of wild-type p53 inhibits the ability of Z to disrupt viral latency. Likewise, Z inhibits p53-dependent transactivation in lymphoid cells. The direct interaction between Z and p53 may play a role in regulating the switch from latent to lytic viral infection.

This article has been cited by other articles:

• Munoz-Fontela, C., Garcia, M. A., Collado, M., Marcos-Villar, L., Gallego, P., Esteban, M., Rivas, C. (2007). Control of virus infection by tumour suppressors. Carcinogenesis 28: 1140-1144 [Abstract] [Full Text]  
• Wen, W., Iwakiri, D., Yamamoto, K., Maruo, S., Kanda, T., Takada, K. (2007). Epstein-Barr Virus BZLF1 Gene, a Switch from Latency to Lytic Infection, Is Expressed as an Immediate-Early Gene after Primary Infection of B Lymphocytes. J. Virol. 81: 1037-1042 [Abstract] [Full Text]  
• Wang, P., Day, L., Lieberman, P. M. (2006). Multivalent Sequence Recognition by Epstein-Barr Virus Zta Requires Cysteine 171 and an Extension of the Canonical B-ZIP Domain. J. Virol. 80: 10942-10949 [Abstract] [Full Text]  
• Yip, K. W., Shi, W., Pintilie, M., Martin, J. D., Mocanu, J. D., Wong, D., MacMillan, C., Gullane, P., O'Sullivan, B., Bastianutto, C., Liu, F.-F. (2006). Prognostic Significance of the Epstein-Barr Virus, p53, Bcl-2, and Survivin in Nasopharyngeal Cancer.. Clin. Cancer Res. 12: 5726-5732 [Abstract] [Full Text]  
• Surjit, M., Liu, B., Chow, V. T. K., Lal, S. K. (2006). The Nucleocapsid Protein of Severe Acute Respiratory Syndrome-Coronavirus Inhibits the Activity of Cyclin-Cyclin-dependent Kinase Complex and Blocks S Phase Progression in Mammalian Cells. J. Biol. Chem. 281: 10669-10681 [Abstract] [Full Text]  
• Arbach, H., Viglasky, V., Lefeu, F., Guinebretiere, J.-M., Ramirez, V., Bride, N., Boualaga, N., Bauchet, T., Peyrat, J.-P., Mathieu, M.-C., Mourah, S., Podgorniak, M.-P., Seignerin, J.-M., Takada, K., Joab, I. (2006). Epstein-Barr Virus (EBV) Genome and Expression in Breast Cancer Tissue: Effect of EBV Infection of Breast Cancer Cells on Resistance to Paclitaxel (Taxol). J. Virol. 80: 845-853 [Abstract] [Full Text]  
• Wang, P., Day, L., Dheekollu, J., Lieberman, P. M. (2005). A Redox-Sensitive Cysteine in Zta Is Required for Epstein-Barr Virus Lytic Cycle DNA Replication. J. Virol. 79: 13298-13309 [Abstract] [Full Text]  
• Adamson, A. L., Wright, N., LaJeunesse, D. R. (2005). Modeling Early Epstein-Barr Virus Infection in Drosophila melanogaster: The BZLF1 Protein. Genetics 171: 1125-1135 [Abstract] [Full Text]  
• Takemoto, M., Koike, M., Mori, Y., Yonemoto, S., Sasamoto, Y., Kondo, K., Uchiyama, Y., Yamanishi, K. (2005). Human Herpesvirus 6 Open Reading Frame U14 Protein and Cellular p53 Interact with Each Other and Are Contained in the Virion. J. Virol. 79: 13037-13046 [Abstract] [Full Text]  
• Izumiya, Y., Ellison, T. J., Yeh, E. T. H., Jung, J. U., Luciw, P. A., Kung, H.-J. (2005). Kaposi's Sarcoma-Associated Herpesvirus K-bZIP Represses Gene Transcription via SUMO Modification. J. Virol. 79: 9912-9925 [Abstract] [Full Text]  
• Hahn, A. M., Huye, L. E., Ning, S., Webster-Cyriaque, J., Pagano, J. S. (2005). Interferon Regulatory Factor 7 Is Negatively Regulated by the Epstein-Barr Virus Immediate-Early Gene, BZLF-1. J. Virol. 79: 10040-10052 [Abstract] [Full Text]  
• Adamson, A. L. (2005). Epstein-Barr Virus BZLF1 Protein Binds to Mitotic Chromosomes. J. Virol. 79: 7899-7904 [Abstract] [Full Text]  
• Al Mehairi, S., Cerasoli, E., Sinclair, A. J. (2005). Investigation of the Multimerization Region of the Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Protein K-bZIP: the Proposed Leucine Zipper Region Encodes a Multimerization Domain with an Unusual Structure. J. Virol. 79: 7905-7910 [Abstract] [Full Text]  
• Kudoh, A., Fujita, M., Zhang, L., Shirata, N., Daikoku, T., Sugaya, Y., Isomura, H., Nishiyama, Y., Tsurumi, T. (2005). Epstein-Barr Virus Lytic Replication Elicits ATM Checkpoint Signal Transduction While Providing an S-phase-like Cellular Environment. J. Biol. Chem. 280: 8156-8163 [Abstract] [Full Text]  
• Boutell, C., Everett, R. D. (2004). Herpes Simplex Virus Type 1 Infection Induces the Stabilization of p53 in a USP7- and ATM-Independent Manner. J. Virol. 78: 8068-8077 [Abstract] [Full Text]  
• El-Guindy, A. S., Miller, G. (2004). Phosphorylation of Epstein-Barr Virus ZEBRA Protein at Its Casein Kinase 2 Sites Mediates Its Ability To Repress Activation of a Viral Lytic Cycle Late Gene by Rta. J. Virol. 78: 7634-7644 [Abstract] [Full Text]  
• Takemoto, M., Mori, Y., Ueda, K., Kondo, K., Yamanishi, K. (2004). Productive human herpesvirus 6 infection causes aberrant accumulation of p53 and prevents apoptosis. J. Gen. Virol. 85: 869-879 [Abstract] [Full Text]  
• Izumiya, Y., Lin, S.-F., Ellison, T. J., Levy, A. M., Mayeur, G. L., Izumiya, C., Kung, H.-J. (2003). Cell Cycle Regulation by Kaposi's Sarcoma-Associated Herpesvirus K-bZIP: Direct Interaction with Cyclin-CDK2 and Induction of G1 Growth Arrest. J. Virol. 77: 9652-9661 [Abstract] [Full Text]  
• Sinclair, A. J. (2003). bZIP proteins of human gammaherpesviruses. J. Gen. Virol. 84: 1941-1949 [Abstract] [Full Text]  
• Johansen, L. M., Deppmann, C. D., Erickson, K. D., Coffin, W. F. III, Thornton, T. M., Humphrey, S. E., Martin, J. M., Taparowsky, E. J. (2003). EBNA2 and Activated Notch Induce Expression of BATF. J. Virol. 77: 6029-6040 [Abstract] [Full Text]  
• Thomas, C., Dankesreiter, A., Wolf, H., Schwarzmann, F. (2003). The BZLF1 promoter of Epstein-Barr virus is controlled by E box-/HI-motif-binding factors during virus latency. J. Gen. Virol. 84: 959-964 [Abstract] [Full Text]  
• Mauser, A., Saito, S.'i., Appella, E., Anderson, C. W., Seaman, W. T., Kenney, S. (2002). The Epstein-Barr Virus Immediate-Early Protein BZLF1 Regulates p53 Function through Multiple Mechanisms. J. Virol. 76: 12503-12512 [Abstract] [Full Text]  
• Mauser, A., Holley-Guthrie, E., Zanation, A., Yarborough, W., Kaufmann, W., Klingelhutz, A., Seaman, W. T., Kenney, S. (2002). The Epstein-Barr Virus Immediate-Early Protein BZLF1 Induces Expression of E2F-1 and Other Proteins Involved in Cell Cycle Progression in Primary Keratinocytes and Gastric Carcinoma Cells. J. Virol. 76: 12543-12552 [Abstract] [Full Text]  
• Lok, S.S., Haider, Y., Howell, D., Stewart, J.P., Hasleton, P.S., Egan, J.J. (2002). Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice. Eur Respir J 20: 1228-1232 [Abstract] [Full Text]  
• Keating, S., Prince, S., Jones, M., Rowe, M. (2002). The Lytic Cycle of Epstein-Barr Virus Is Associated with Decreased Expression of Cell Surface Major Histocompatibility Complex Class I and Class II Molecules. J. Virol. 76: 8179-8188 [Abstract] [Full Text]  
• Adler, B., Schaadt, E., Kempkes, B., Zimber-Strobl, U., Baier, B., Bornkamm, G. W. (2001). Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1. Proc. Natl. Acad. Sci. USA 10.1073/pnas.221439999v1 [Abstract] [Full Text]  
• Quintanilla-Martinez, L., Kremer, M., Keller, G., Nathrath, M., Gamboa-Dominguez, A., Meneses, A., Luna-Contreras, L., Cabras, A., Hoefler, H., Mohar, A., Fend, F. (2001). p53 Mutations in Nasal Natural Killer/T-Cell Lymphoma from Mexico : Association with Large Cell Morphology and Advanced Disease. Am. J. Pathol. 159: 2095-2105 [Abstract] [Full Text]  
• Deng, Z., Chen, C.-J., Zerby, D., Delecluse, H.-J., Lieberman, P. M. (2001). Identification of Acidic and Aromatic Residues in the Zta Activation Domain Essential for Epstein-Barr Virus Reactivation. J. Virol. 75: 10334-10347 [Abstract] [Full Text]  
• Adamson, A. L., Kenney, S. (2001). Epstein-Barr Virus Immediate-Early Protein BZLF1 Is SUMO-1 Modified and Disrupts Promyelocytic Leukemia Bodies. J. Virol. 75: 2388-2399 [Abstract] [Full Text]  
• Park, J., Seo, T., Hwang, S., Lee, D., Gwack, Y., Choe, J. (2000). The K-bZIP Protein from Kaposi's Sarcoma-Associated Herpesvirus Interacts with p53 and Represses Its Transcriptional Activity. J. Virol. 74: 11977-11982 [Abstract] [Full Text]  
• Lukens, A. K., King, D. A., Marmorstein, R. (2000). Structure of HAP1-PC7 bound to DNA: implications for DNA recognition and allosteric effects of DNA-binding on transcriptional activation. Nucleic Acids Res 28: 3853-3863 [Abstract] [Full Text]  
• Chang, L.-K., Liu, S.-T. (2000). Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation. Nucleic Acids Res 28: 3918-3925 [Abstract] [Full Text]  
• Ortiz, M. R., Garijo, G., Adrados, M., Lopez-Bonet, E., Acero, D., Bernado, L. (2000). Epstein-Barr Virus-Associated Cholangiocarcinoma with Lymphoepithelioma-Like Component. INT J SURG PATHOL 8: 347-351 [Abstract]  
• Lu, J., Chen, S.-Y., Chua, H.-H., Liu, Y.-S., Huang, Y.-T., Chang, Y., Chen, J.-Y., Sheen, T.-S., Tsai, C.-H. (2000). Upregulation of Tyrosine Kinase TKT by the Epstein-Barr Virus Transactivator Zta. J. Virol. 74: 7391-7399 [Abstract] [Full Text]  
• Dreyfus, D. H., Nagasawa, M., Kelleher, C. A., Gelfand, E. W. (2000). Stable expression of Epstein-Barr virus BZLF-1-encoded ZEBRA protein activates p53-dependent transcription in human Jurkat T-lymphoblastoid cells. Blood 96: 625-634 [Abstract] [Full Text]  
• Aho, S., Buisson, M., Pajunen, T., Ryoo, Y. W., Giot, J.-F., Gruffat, H., Sergeant, A., Uitto, J. (2000). Ubinuclein, a Novel Nuclear Protein Interacting with Cellular and Viral Transcription Factors. J. Cell Biol. 148: 1165-1176 [Abstract] [Full Text]  
• Dreyfus, D. H., Nagasawa, M., Pratt, J. C., Kelleher, C. A., Gelfand, E. W. (1999). Inactivation of NF-{kappa}B by EBV BZLF-1-Encoded ZEBRA Protein in Human T Cells. J. Immunol. 163: 6261-6268 [Abstract] [Full Text]  
• Swenson, J. J., Mauser, A. E., Kaufmann, W. K., Kenney, S. C. (1999). The Epstein-Barr Virus Protein BRLF1 Activates S Phase Entry through E2F1 Induction. J. Virol. 73: 6540-6550 [Abstract] [Full Text]  
• Adamson, A. L., Kenney, S. (1999). The Epstein-Barr Virus BZLF1 Protein Interacts Physically and Functionally with the Histone Acetylase CREB-Binding Protein. J. Virol. 73: 6551-6558 [Abstract] [Full Text]  
• Edinger, J. W., Bonneville, M., Scotet, E., Houssaint, E., Schumacher, H. R., Posnett, D. N. (1999). EBV Gene Expression Not Altered in Rheumatoid Synovia Despite the Presence of EBV Antigen-Specific T Cell Clones. J. Immunol. 162: 3694-3701 [Abstract] [Full Text]  
• Zerby, D., Chen, C.-J., Poon, E., Lee, D., Shiekhattar, R., Lieberman, P. M. (1999). The Amino-Terminal C/H1 Domain of CREB Binding Protein Mediates Zta Transcriptional Activation of Latent Epstein-Barr Virus. Mol. Cell. Biol. 19: 1617-1626 [Abstract] [Full Text]  
• Prikhod'ko, G. G., Wang, Y., Freulich, E., Prives, C., Miller, L. K. (1999). Baculovirus p33 Binds Human p53 and Enhances p53-Mediated Apoptosis. J. Virol. 73: 1227-1234 [Abstract] [Full Text]  
• Sarid, R., Wiezorek, J. S., Moore, P. S., Chang, Y. (1999). Characterization and Cell Cycle Regulation of the Major Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Latent Genes and Their Promoter. J. Virol. 73: 1438-1446 [Abstract] [Full Text]  
• Gao, Z., Krithivas, A., Finan, J. E., Semmes, O. J., Zhou, S., Wang, Y., Hayward, S. D. (1998). The Epstein-Barr Virus Lytic Transactivator Zta Interacts with the Helicase-Primase Replication Proteins. J. Virol. 72: 8559-8567 [Abstract] [Full Text]  
• Ragoczy, T., Heston, L., Miller, G. (1998). The Epstein-Barr Virus Rta Protein Activates Lytic Cycle Genes and Can Disrupt Latency in B Lymphocytes. J. Virol. 72: 7978-7984 [Abstract] [Full Text]  
• Zacny, V. L., Wilson, J., Pagano, J. S. (1998). The Epstein-Barr Virus Immediate-Early Gene Product, BRLF1, Interacts with the Retinoblastoma Protein during the Viral Lytic Cycle. J. Virol. 72: 8043-8051 [Abstract] [Full Text]  
• Baumann, M., Mischak, H., Dammeier, S., Kolch, W., Gires, O., Pich, D., Zeidler, R., Delecluse, H.-J., Hammerschmidt, W. (1998). Activation of the Epstein-Barr Virus Transcription Factor BZLF1 by 12-O-Tetradecanoylphorbol-13-Acetate-Induced Phosphorylation. J. Virol. 72: 8105-8114 [Abstract] [Full Text]  
• Perz, E., Kuhn, J. G. (1998). Review : p53 in the pathogenesis, diagnosis, and treatment of cancer. J Oncol Pharm Pract 4: 75-102 [Abstract]  
• Pise-Masison, C. A., Choi, K.-S., Radonovich, M., Dittmer, J., Kim, S.-J., Brady, J. N. (1998). Inhibition of p53 Transactivation Function by the Human T-Cell Lymphotropic Virus Type 1 Tax Protein. J. Virol. 72: 1165-1170 [Abstract] [Full Text]  
• Liu, J.-L., Ye, Y., Lee, L. F., Kung, H.-J. (1998). Transforming Potential of the Herpesvirus Oncoprotein MEQ: Morphological Transformation, Serum-Independent Growth, and Inhibition of Apoptosis. J. Virol. 72: 388-395 [Abstract] [Full Text]  
• Prang, N. S., Hornef, M. W., Jager, M., Wagner, H. J., Wolf, H., Schwarzmann, F. M. (1997). Lytic Replication of Epstein-Barr Virus in the Peripheral Blood: Analysis of Viral Gene Expression in B Lymphocytes During Infectious Mononucleosis and in the Normal Carrier State. Blood 89: 1665-1677 [Abstract] [Full Text]  
• Ko, L J, Prives, C (1996). p53: puzzle and paradigm.. Genes Dev. 10: 1054-1072  
• Tsai, H.-L., Kou, G.-H., Chen, S.-C., Wu, C.-W., Lin, Y.-S. (1996). Human Cytomegalovirus Immediate-Early Protein IE2 Tethers a Transcriptional Repression Domain to p53. J. Biol. Chem. 271: 3534-3540 [Abstract] [Full Text]  
• Speir, E, Modali, R, Huang, E., Leon, M., Shawl, F, Finkel, T, Epstein, S. (1994). Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265: 391-394 [Abstract]  
• Ogden, S. K., Lee, K. C., Barton, M. C. (2000). Hepatitis B Viral Transactivator HBx Alleviates p53-mediated Repression of alpha -Fetoprotein Gene Expression. J. Biol. Chem. 275: 27806-27814 [Abstract] [Full Text]  
• Adler, B., Schaadt, E., Kempkes, B., Zimber-Strobl, U., Baier, B., Bornkamm, G. W. (2002). Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1. Proc. Natl. Acad. Sci. USA 99: 437-442 [Abstract] [Full Text]